[{"id":"bb4d0ace-2645-4450-8959-030249d87872","acronym":"NSABP FB-14","url":"https://clinicaltrials.gov/study/NCT04024800","created_at":"2021-01-18T19:45:32.207Z","updated_at":"2025-02-25T16:09:19.539Z","phase":"Phase 2","brief_title":"Establishing the Recommended Biological Dose for AE37 Peptide Vaccine in Combination With Pembrolizumab That Will Enhance the Tumor-specific Immune Response and Demonstrate Efficacy in Patients With Advanced Triple-negative Breast Cancer","source_id_and_acronym":"NCT04024800 - NSABP FB-14","lead_sponsor":"NuGenerex Immuno-Oncology","biomarkers":" HER-2","pipe":" | ","alterations":" HER-2 negative","tags":["HER-2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e Keytruda (pembrolizumab) • AE 37"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 29","initiation":"Initiation: 05/03/2019","start_date":" 05/03/2019","primary_txt":" Primary completion: 06/30/2023","primary_completion_date":" 06/30/2023","study_txt":" Completion: 06/30/2024","study_completion_date":" 06/30/2024","last_update_posted":"2021-06-02"},{"id":"980e1068-fd01-44b1-b3ab-8466fd9acc2c","acronym":"BAMC-C.2007.098","url":"https://clinicaltrials.gov/study/NCT00524277","created_at":"2021-01-18T01:53:39.730Z","updated_at":"2024-07-02T16:36:47.236Z","phase":"Phase 2","brief_title":"Vaccine Therapy in Treating Patients With Breast Cancer","source_id_and_acronym":"NCT00524277 - BAMC-C.2007.098","lead_sponsor":"San Antonio Military Medical Center","biomarkers":" HER-2 • ER • PGR • CSF2","pipe":" | ","alterations":" HER-2 amplification • HER-2 expression • HLA-A2 positive • PGR negative","tags":["HER-2 • ER • PGR • CSF2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HER-2 amplification • HER-2 expression • HLA-A2 positive • PGR negative"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AE 37 • GLSI-100 • Leukine (sargramostim)"],"overall_status":"Completed","enrollment":" Enrollment 456","initiation":"Initiation: 01/01/2007","start_date":" 01/01/2007","primary_txt":" Primary completion: 12/31/2014","primary_completion_date":" 12/31/2014","study_txt":" Completion: 03/31/2017","study_completion_date":" 03/31/2017","last_update_posted":"2020-03-30"}]